Believe It Pe/cyanine7 Anti-human Cd27 Get 55% Off Today [tSFhUW8y]

PE/Cyanine7 Anti-Human CD27 Antibody

Introducing the PE/Cyanine7 Anti-Human CD27 Antibody, a highly specialized monoclonal antibody designed for immunofluorescence and flow cytometry applications. This antibody is specifically engineered to recognize and bind to human CD27, a crucial member of the TNF-receptor superfamily. Known for its expression on a wide range of immune cells, CD27 plays a pivotal role in T cell activation, B cell differentiation, and NK cell function. With its exceptional binding affinity and specificity, this antibody is an essential tool for researchers investigating the complex interactions within the immune system.

Product Specifications and Benefits

Our PE/Cyanine7 Anti-Human CD27 Antibody is produced using a mouse monoclonal clone (S20020G) and conjugated to PE-Cyanine7 for optimal fluorescence. The antibody is reactive against human CD27 and is ideal for use in flow cytometry applications. Here are some key features and benefits of this product:

• High Sensitivity: Detects low-level CD27 expression with exceptional sensitivity.
• Specificity: High specificity for human CD27 ensures minimal cross-reactivity.
• Conjugation: PE-Cyanine7 conjugation provides bright and stable fluorescence for easy detection.

This antibody is also available in various formats, including unconjugated, which can be conjugated to other fluorochromes as needed.

Applications and Target Audience

Our PE/Cyanine7 Anti-Human CD27 Antibody is a versatile tool for researchers studying the immune system, particularly in the areas of T cell activation, B cell differentiation, and NK cell function. Ideal for use in flow cytometry, this antibody is suitable for a wide range of applications, including:

• Immunophenotyping: Characterize and differentiate immune cells based on CD27 expression.
• Functional Assays: Investigate the role of CD27 in T cell activation and B cell differentiation.

This product is particularly valuable for researchers in immunology, oncology, and infectious diseases, as well as for those involved in drug discovery and development.